Page last updated: 2024-11-02

pindolol and Skin Neoplasms

pindolol has been researched along with Skin Neoplasms in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaila, T1
Penttinen, R1
Peltonen, J1

Other Studies

1 other study available for pindolol and Skin Neoplasms

ArticleYear
Cultured neurofibromatosis tumor fibroblasts lack beta-adrenergic receptors.
    Neurofibromatosis, 1988, Volume: 1, Issue:1

    Topics: Fibroblasts; Humans; Iodocyanopindolol; Neurofibromatosis 1; Pindolol; Receptors, Adrenergic, beta;

1988